← Leaderboards
Ze Lu
Optimum Therapeutics, Llc
$4,574,613
Attributed
$5,022,543
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,022,543 · 8
By mechanism
R44$2,833,025 · 2
R43$2,189,518 · 6
Top collaborators
- Jessie L.-S. Au3 shared
- Jie Wang2 shared
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsPaclitaxelPharmaceutical PreparationsTumorDoseToxic EffectIn VivoApoptosisAnimalsDoxorubicinCanis FamiliarisStagingExcisionMalignant NeoplasmsAccountingPropertyPenetrationEvaluationNeoplastic CellBladder NeoplasmCollaborationsOperative Surgical ProceduresAdjuvantDrug Formulations
Grant awards (16)
Combination chemo-siRNA gene therapy of nonmuscle-invading bladder cancer$344,460
R43 · FY2012 · TR · contact PI
Intra-bladder MMC & suramin for nonmuscle-invading & locally advanced bladder ca$105,157
R43 · FY2012 · CA · contact PI
Apoptosis Inducing to Enhance Tumor Targeting$50,000
R44 · FY2012 · CA · contact PI
Intra-bladder MMC & suramin for nonmuscle-invading & locally advanced bladder ca$198,069
R43 · FY2011 · CA · contact PI
Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy$645,019
R44 · FY2009 · CA · contact PI
Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy$400,000
R44 · FY2009 · CA · contact PI
Intraperitoneal Tumor-Targeting Chemo-gene Therapy$125,561
R43 · FY2009 · CA
Rapid release paclitaxel nanoparticles for bladder cancer intravestical therapy$730,684
R44 · FY2008 · CA · contact PI
Intraperitoneal Tumor-Targeting Chemo-gene Therapy$122,613
R43 · FY2008 · CA
Apoptosis Inducing to Enhance Tumor Targeting$565,979
R44 · FY2007 · CA · contact PI
Tumor-priming Microparticles for Pancreatic Cancer$441,343
R44 · FY2006 · CA · contact PI
Bladder Tumor Targeting by Intravesical Paclitaxel$300,157
R43 · FY2005 · CA
FGFs to Broadly Protect Chemotherapy-Induced Alopecia$197,840
R43 · FY2005 · CA
Bladder Tumor Targeting by Intravesical Paclitaxel$300,157
R43 · FY2004 · CA
Apoptosis Inducing to Enhance Tumor Targeting$249,199
R43 · FY2004 · CA
Apoptosis Inducing to Enhance Tumor Targeting$246,305
R43 · FY2003 · CA